..., scotomas, transient flashing of the eyes, and sudden transient partial blindness preceded or followed erythromelalgia in the toes or fingers. The time lapse between the first symptoms of aspirin-responsive MIAs and the diagnosis of ET in 5 patients ranged from 4 to 12 years. At the time of erythromelalgia...

... and in patients. Platelet-rich plasma derived from 13 out of 23 patients, spontaneously aggregatedeven when kept at 23 °C. Spontaneous platelet aggregation was inhibited by aspirin 4 3 2009 © 1973 S. Karger AG, Basel 1973 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part...

... 10 days of aspirin therapy, some abnormalities were significantly reduced. The implications of this finding are discussed. 6 03 1980 4 07 1980 27 2 2009 © 1980 S. Karger AG, Basel 1980 Copyright / Drug Dosage / Disclaimer Copyright: All rights reserved. No part...

.... Primary aggregation Platelet Glucagon Aspirin Acta haemat. 64: 6-11 (1980) Increased Platelet Aggregation Induced by Glucagon Administration Stephen J. Proctor, Terry F. Davies, Alan Oxley, Peter Jones and Alan Heath Endocrine Unit, Department of Medicine and Department of Haematology, Royal...

...M. Djaldetti; P. Fishman; D. Creter; I. Notti The in vitro effect of diclofenac sodium (Voltaren) on the ultrastructure of healthy donors’ platelets was examined and compared with those induced by aspirin (ASA). In distinction to ASA, which causes loss of platelet pseudopodia, Voltaren induced...

...N.O. Osamo; D.P. Photiades; A.A. Famodu This work was carried out to demonstrate the possibility of beneficial therapeutic effects of aspirin in sickle cell anaemia patients. Two groups of 50 patients each, with haemoglobin genotype SS were studied, one group receiving soluble aspirin daily for 6...

...M.A. Zago; F.F. Costa; S.J. Ismael; L.G. Tone; C. Bottura The effects of long-term aspirin for the treatment of sickle cell disease were compared with placebo in a double-blind trial completed by 29 patients. Each patient was submitted to a 5-month period of treatment with aspirin (median dose 31...

... to in the content or advertisements. Aspirin Idiopathic hypereosinophilic syndrome Vincristine Actahaemat. 72: 21-25(1984) © 1984 S. Karger A G , Basel 0001-5792/84/0721-0021 S 2.75/0 Response to Vincristine Treatment in a Case of Idiopathic Hyperéosinophilie Syndrome with Multiple Clinical...

...M.D. Djaldetti; P. Fishman; A. Cohen; E. Roffman; H. Levinsky; M. Glaser; I. Zahavi Platelets incubated with prostaglandin synthetase inhibitors, i.e. aspirin (ASA) and diclofenac-sodium (Voltaren) show a decreased capability to aggregate. While ASA induces the complete loss of platelet pseudopodia...

... dysfunction and 2 patients with von Willebrand’s disease the pattern of platelet retention was affected principally in its early phase, whereas aspirin, when given to 2 healthy subjects, inhibited platelet retention predominantly in its late phase. Our modified platelet retention test provides information...

... of erythropoietin-treated rats was measured compared to their baseline values. However, aspirin (a prostaglandin synthesis inhibitor) intake along with recombinant erythropoietin administration totally abolished the reversion of hemoglobin proportions toward newborn values, but not the increase in hemoglobin...

... abortion in the first trimester – and the risk of intrauterine fetal death, we believe all patients should at least be treated with aspirin unless there is a contraindication. Platelet reduction with interferon-α (IFN-α) might be able to further reduce the complications of ET during pregnancy...

...Stephan Erhart; Jürg H. Beer; Walter H. Reinhart Platelet volume and total platelet mass are parameters of platelet activity and have become a prognostic factor in coronary heart disease. We have studied the influence of aspirin on platelet count, volume and total platelet mass in vitro...